The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Effect of Interferon-α on cognitive functioning in patients with chronic hepatitis C
Abstract
Treatment with interferon-alpha (IFN-α) has been shown to adversely affect cognitive functioning in patients with a variety of medical disorders, but information about the effects of IFN-α on cognitive functioning in patients with chronic hepatitis C (CHC) is limited. The purpose of this study was to examine the effects of IFN-α on neuropsychological test performance in CHC patients. Participants were 30 patients with CHC, 11 who underwent IFN-α therapy and 19 who did not. All participants were tested at baseline (i.e., pretreatment) and approximately 6 months later with the Symbol Digit Modalities Test and Trail Making Test. Results revealed that the treatment group performed significantly worse than untreated CHC patients on Part B of the Trail Making Test after approximately 6 months of treatment. No significant group differences were found on Part A of the Trail Making Test or Symbol Digit Modalities Test. Findings suggest that CHC patients undergoing treatment with IFN-α may experience reduced abilities to benefit from practice but suffer no decrements in performance after 6 months of treatment. Additional research is needed to replicate these findings and to explore risk factors for susceptibility to IFN-α-induced effects. (JINS, 2005,11, 16–22.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hepatitis C patients who received 6 months of IFN-α performed significantly worse on the TMT part B when compared with hepatitis C patients who did not undergo IFN-α treatment (Hilsabeck et al., 2005)”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Hilsabeck et al., 2005
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,457
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,413
Davis, G. L., Esteban, R., Rustgi, V. K., Hoefs, J. C., Gordon, S. C., TREPO, C. G., Shiffman, M. L., Zeuzem, S., Craxı̀, A., Ling, M.-H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392102 · Cited by 1,271
Foster, G. R., Goldin, R. D., & Thomas, H. C. (1998) · Hepatology · doi:10.1002/hep.510270132 · Cited by 559
DIKMEN, S. S., Heaton, R. K., Grant, I., & Temkin, N. R. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799544056 · Cited by 473
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Wesnes, K. A., & Taylor-Robinson, S. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30688 · Cited by 450
Flagged first, then by citations
1 of the 55 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- de Boer, A.G. & Breimer, D.D. (1998).Cytokines and blood-brain barrier permeability. In H.S. Sharma & J. Westman (Eds.),Progress in brain research, volume 115 (pp.425–451).New York:Elsevier Science.
- Lezak, M.D. (1995).Neuropsychological Assessment(3rd ed.).New York:Oxford University Press.
- Beck, A.T. , Steer, R.A. , & Brown, G.K. (1996).Beck Depression Inventory–Second Edition: Manual.San Antonio, TX:The Psychological Corporation.
Cited by
Sorted by citations
Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 341
Dooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176
Cognitive Dysfunction in Chronic Hepatitis C: A Review
Perry, W., Hilsabeck, R. C., & Hassanein, T. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9896-z · Cited by 148
Self-citationMajer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 120
Metadata
- Authors
- HILSABECK, R. C., HASSANEIN, T. I., ZIEGLER, E. A., CARLSON, M. D., & PERRY, W.
- Affiliations
- Texas Tech University (US)
- University of California San Diego (US)
- Venue
- Journal of the International Neuropsychological Society
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-01
- Volume
- 11
- Issue
- 1
- Pages
- 16-22
- ISSN
- 1355-6177 (ISSN-L)
- 1469-7661
- OpenAlex
- W2150327179
- Cited by
- 40
- References
- 55
- Citations by year
- 2022: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the International Neuropsychological Society (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- interferon-alpha, chronic hepatitis C, cognitive function, neuropsychological performance, Trail Making Test, Symbol Digit Modalities Test, practice effects, antiviral therapy adverse effects
- MeSH terms
- Antiviral Agents, Cognition Disorders, Female, Hepatitis C, Humans, Immunologic Factors, Male, Middle Aged, Neuropsychological Tests, Psychomotor Performance, Treatment Outcome, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
